Physician profile
Sonya Miles
NPI 1023461043
$1,519.68
in general payments reported to CMS, 2019-2025
20 companies · $666 in 2025
The $666 reported for 2025 was more than what 78% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $42.77 · 2022: $92.56 · 2023: $290 · 2024: $428 · 2025: $666.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,384.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,384.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $212.60 | 2022-2025 | |
| Glaxosmithkline, LLC. | $184.08 | 2023-2024 | Bexsero, Pediarix, Rotarix |
| Astrazeneca Pharmaceuticals LP | $179.70 | 2022-2025 | Farxiga, Breztri, Airsupra |
| Novo Nordisk INC | $142.11 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $141.34 | 2021-2024 | Jardiance, Emgality, Mounjaro |
| Indivior INC. | $89.04 | 2024-2025 | Sublocade |
| Tandem Diabetes Care, INC. | $86.45 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Exact Sciences Corporation | $77.44 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Kyowa Kirin, INC. | $59.20 | 2024-2025 | Crysvita |
| Dexcom, INC. | $44.40 | 2024-2025 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $43.89 | 2023-2025 | Gardasil 9, M-M-R II, Proquad |
| Phathom Pharmaceuticals, INC. | $40.88 | 2025 | Voquezna |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.52 | 2021-2022 | |
| Amgen INC. | $39.51 | 2025 | Evenity, Prolia |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $30.61 | 2024-2025 | Caplyta |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultragenyx Pharmaceutical INC. | $27.41 | 2024 | Crysvita |
| Alkermes, INC. | $25.17 | 2025 | Vivitrol |
| Insulet Corporation | $20.04 | 2025 | Omnipod |
| Abbott Laboratories | $17.78 | 2025 | Freestyle Libre 3 |
| Daiichi Sankyo INC. | $17.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonya Miles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.